Paz-Ares L, Spigel DR, Chen Y, Jove M, et al. RESILIENT part 1: A phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer. Cancer 2022 Feb 23. doi: 10.1002/cncr.34123.
PMID: 35195913